Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I combination peptide vaccine immunotherapy in advanced or metastatic colorectal cancer
jRCTs061180034Phase 1Completed
- Start
- May 2016
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in colorectal cancer (CRC). Primary endpoint: Safety. Started May 2016; status: completed.
02
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCTs061180034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180034.